
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Active composition
+1 more active ingredient
Methylcobalamin acts as a cofactor in the synthesis of methionine from homocysteine, promoting nerve health and red blood cell formation.
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Medical applications
Nurorise P Tablet SR is a sustained-release formulation combining Methylcobalamin 1500 mcg and Pregabalin 75 mg, designed for the management of neuropathic pain and associated neurological conditions. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair, supporting the maintenance of healthy nerve function and aiding in the treatment of peripheral neuropathies. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, exerts its therapeutic effect by modulating calcium channels in the central nervous system, thereby reducing neuronal excitability and alleviating neuropathic pain symptoms such as burning, shooting pain, and allodynia. The sustained-release mechanism ensures a gradual and prolonged release of active ingredients, enhancing patient compliance by reducing dosing frequency and maintaining stable plasma drug levels. Nurorise P Tablet SR is indicated for conditions including diabetic neuropathy, postherpetic neuralgia, fibromyalgia, and other neuropathic pain syndromes. It should be used under medical supervision, with careful consideration of patient history, renal function, and potential drug interactions. Common side effects may include dizziness, somnolence, and gastrointestinal disturbances. Dose adjustments may be necessary in renal impairment. Nurorise P Tablet SR offers a synergistic approach to neuropathic pain management by combining neurotrophic support with effective analgesia.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nurorise P Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Nurorise P Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Nurorise P Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Nurorise P Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Nurorise P Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nurorise P Tablet SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Nurorise P Tablet SR may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Nurorise P Tablet SR

Methylcobalamin (1500mcg) + Pregabalin (75mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Methylcobalamin acts as a cofactor in the synthesis of methionine from homocysteine, promoting nerve health and red blood cell formation.
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Medical applications
Nurorise P Tablet SR is a sustained-release formulation combining Methylcobalamin 1500 mcg and Pregabalin 75 mg, designed for the management of neuropathic pain and associated neurological conditions. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair, supporting the maintenance of healthy nerve function and aiding in the treatment of peripheral neuropathies. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, exerts its therapeutic effect by modulating calcium channels in the central nervous system, thereby reducing neuronal excitability and alleviating neuropathic pain symptoms such as burning, shooting pain, and allodynia. The sustained-release mechanism ensures a gradual and prolonged release of active ingredients, enhancing patient compliance by reducing dosing frequency and maintaining stable plasma drug levels. Nurorise P Tablet SR is indicated for conditions including diabetic neuropathy, postherpetic neuralgia, fibromyalgia, and other neuropathic pain syndromes. It should be used under medical supervision, with careful consideration of patient history, renal function, and potential drug interactions. Common side effects may include dizziness, somnolence, and gastrointestinal disturbances. Dose adjustments may be necessary in renal impairment. Nurorise P Tablet SR offers a synergistic approach to neuropathic pain management by combining neurotrophic support with effective analgesia.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nurorise P Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Nurorise P Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Nurorise P Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Nurorise P Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Nurorise P Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nurorise P Tablet SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Nurorise P Tablet SR may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Nurorise P Tablet SR















